AI-native biotechnology developing novel oncology therapeutics through a simulation-first approach that integrates computational biology with experimental validation. Proprietary AI platform generates, evaluates, and optimizes drug candidates via predictive modeling and a continuous in silico–experimental feedback loop to accelerate discovery and improve success probability.